Desipramine
Based on 18 publication(s) in Google Scholar
Desipramine is a first-generation tricyclic antidepressant. Desipramine selectively binds to norepinephrine transporter and blocks neuronal norepinephrine reuptake. Desipramine activates MAPK signaling via ERK1/2, JNK, and p38, represses NF-κB and AP-1 activity, and induces apoptosis via ROS elevation, mitochondrial membrane potential reduction, and intracellular calcium increase. Desipramine also shows anyi-inflammatory activity, inhibiting TNF-α production. Desipramine can be used for the research of hepatocellular cancer, inflammation, and neurological diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 50-47-5
- Formel: C18H22N2
- Molecular Weight:266.38
-
Speicherung:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Desipramine
More- Cell. 2025 Nov 26;188(24):6861-6872.e14. [Abstract]
- Acta Pharm Sin B. 2026 Jan 27.
- Neural Regen Res. 2021 Aug;16(8):1660-1670. [Abstract]
- Br J Pharmacol. 2024 Dec;181(23):4874-4889. [Abstract]
- J Med Chem. 2026 Feb 10. [Abstract]
- Pharmaceutics. 2022 Jul 22;14(8):1523. [Abstract]
- J Parkinson Dis. 2020;10(2):523-542. [Abstract]
- Front Endocrinol. 2026 May 5:17:1825379. [Abstract]
- Glia. 2022 Nov;70(11):2093-2107. [Abstract]
- Inflammation. 2021 Aug;44(4):1592-1606. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2023 Mar 28;1869(5):166700. [Abstract]
- Neuropharmacology. 2026 Nov 1:298:111009. [Abstract]
- Neurotoxicology. 2022 Dec:93:173-185. [Abstract]
- Drug Metab Dispos. 2026 Jul 14;54(8):100365.
- Neuroscience. 2024 Mar 26:542:11-20. [Abstract]
- Parkinsons Dis. 2022 Nov 14:2022:1428817. [Abstract]
- Sci Total Environ. 2024 May 1:923:171405. [Abstract]
- Research Square Print. 2023 Feb 23.
-
Cell Proliferation/Viability Assay
-
WB
-
Cell Imaging/Staining
-
Bio/Physico-chemical Assay
-
Bio/Physico-chemical Assay
Alle Adrenergic Receptor Isoform-spezifische Produkte anzeigen
MoreAlle AP-1 Isoform-spezifische Produkte anzeigen
MoreAlle TNF Receptor Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
ERK1 |
ERK2 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DG-75 | IC50 |
39.81 μM
Compound: Desipramine
|
Reduction in cell viability of human DG75 cells after 24 hrs by Alamar blue viability assay
Reduction in cell viability of human DG75 cells after 24 hrs by Alamar blue viability assay
|
[PMID: 23385211] |
| HEK293 | IC50 |
0.0524 μM
Compound: desipramine
|
Inhibition of [3H]serotonin uptake in human SERT K490T mutant transfected HEK293 cells
Inhibition of [3H]serotonin uptake in human SERT K490T mutant transfected HEK293 cells
|
[PMID: 17690258] |
| HEK293 | IC50 |
0.108 μM
Compound: desipramine
|
Inhibition of [3H]serotonin uptake in human wild type SERT transfected HEK293 cells
Inhibition of [3H]serotonin uptake in human wild type SERT transfected HEK293 cells
|
[PMID: 17690258] |
| HEK293 | IC50 |
17.7 μM
Compound: desipramine
|
Inhibition of [3H]dopamine uptake in human DAT I390V mutant transfected HEK293 cells
Inhibition of [3H]dopamine uptake in human DAT I390V mutant transfected HEK293 cells
|
[PMID: 17690258] |
| HEK293 | IC50 |
47.9 μM
Compound: desipramine
|
Inhibition of [3H]dopamine uptake in human wild type DAT transfected HEK293 cells
Inhibition of [3H]dopamine uptake in human wild type DAT transfected HEK293 cells
|
[PMID: 17690258] |
| HEK293 | IC50 |
50.5 μM
Compound: desipramine
|
Inhibition of [3H]dopamine uptake in human DAT P387A mutant transfected HEK293 cells
Inhibition of [3H]dopamine uptake in human DAT P387A mutant transfected HEK293 cells
|
[PMID: 17690258] |
| HEK293 | IC50 |
9.9 μM
Compound: desipramine
|
Inhibition of [3H]dopamine uptake in human DAT F472L mutant transfected HEK293 cells
Inhibition of [3H]dopamine uptake in human DAT F472L mutant transfected HEK293 cells
|
[PMID: 17690258] |
| HEK293 | IC50 |
0.0042 μM
Compound: Desipramine
|
Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells
Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells
|
[PMID: 17846138] |
| HEK293 | IC50 |
0.064 μM
Compound: Desipramine
|
Inhibition of [3H]5HT uptake at human SERT expressed in HEK293 cells
Inhibition of [3H]5HT uptake at human SERT expressed in HEK293 cells
|
[PMID: 17846138] |
| HEK293 | IC50 |
82 μM
Compound: Desipramine
|
Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells
Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells
|
[PMID: 17846138] |
| HEK293 | IC50 |
56.8 μM
Compound: desipramine
|
Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy
Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy
|
[PMID: 18788725] |
| HEK293 | IC50 |
1520 nM
Compound: Desipramine
|
Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA
Inhibition of sodium current measured using whole-cell patch clamp experiments in HEK-293 cells stably transfected with hNaV1.5 cDNA
|
[PMID: 21300721] |
| HEK293 | IC50 |
9.18 μM
Compound: Desipramine
|
Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay
Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay
|
[PMID: 28230985] |
| HeLa | IC50 |
17.78 μM
Compound: Desipramine
|
Reduction in cell viability of human HeLa cells after 24 hrs by Alamar blue viability assay
Reduction in cell viability of human HeLa cells after 24 hrs by Alamar blue viability assay
|
[PMID: 23385211] |
| HRPE | IC50 |
0.08 mM
Compound: Desipramine
|
TP_TRANSPORTER: inhibition of TEA uptake in Octn1-HRPE cells
TP_TRANSPORTER: inhibition of TEA uptake in Octn1-HRPE cells
|
[PMID: 10825452] |
| HRPE | IC50 |
68 μM
Compound: Desipramine
|
TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells
TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells
|
[PMID: 9830022] |
| MDCK | IC50 |
0.93 nM
Compound: desipramine
|
Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane
Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane
|
[PMID: 16989524] |
| MDCK | IC50 |
3.9 nM
Compound: desipramine
|
Inhibition of norepinephrine uptake at human NET expressed in MDCK cells
Inhibition of norepinephrine uptake at human NET expressed in MDCK cells
|
[PMID: 18771916] |
| MDCK | IC50 |
0.93 nM
Compound: desipramine
|
Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs
Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs
|
[PMID: 23403082] |
| MDCK | IC50 |
1.5 nM
Compound: Desipramine
|
Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells
Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells
|
[PMID: 24012181] |
| Splenocyte | IC50 |
22.9 μM
Compound: Desipramine
|
Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay
Cytotoxicity against C57BL/6J mouse splenocytes after 72 hrs by alamar blue assay
|
[PMID: 17846138] |
| Ventricular myocyte | IC50 |
1709 nM
Compound: Desipramine
|
Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes
Inhibition of calcium current (ICaL) measured using whole-cell patch clamp experiments in isolated guinea pig ventricular myocytes
|
[PMID: 21300721] |
| Ventricular myocyte | IC50 |
1.709 μM
Compound: Desipramine
|
Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes
|
[PMID: 22761000] |
| Ventricular myocyte | IC50 |
11.7 μM
Compound: Desipramine
|
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
|
[PMID: 22761000] |
In Vitro
Desipramine (3-500 µM; 24 h) reduces the viability of human hepatoma Hep3B cells in a dose-dependent manner[1].
Desipramine (10-500 µM; 24 h) induces cytotoxicity in human hepatoma Hep3B cells in a dose-dependent manner, as measured by increased LDH release[1].
Desipramine (3-100 µM; 24 h) increases intracellular ROS production in human hepatoma Hep3B cells in a dose-dependent manner[1].
Desipramine (3-100 µM µM; 24 h) has its induced cell death in human hepatoma Hep3B cells abolished by the ROS scavenger NAC (HY-B0215) at concentrations up to 30 µM, and partially reduced at 100 µM after 24 h[1].
Desipramine (3-100 µM; 24 h) reduces mitochondrial membrane potential in human hepatoma Hep3B cells in vitro in a dose-dependent manner[1].
Desipramine (100 µM; 1-8 h) activates ERK1/2, JNK, and p38 MAPK signaling in human hepatoma Hep3B cells-[1].
Desipramine (3-100 µM; 24 h) has its induced cell death in human hepatoma Hep3B cells abolished by inhibition of ERK1/2, p38, or JNK MAPK signaling[1].
Desipramine (30-500 µM) increases intracellular calcium levels in human hepatoma Hep3B cells in a concentration-dependent manner, with increases occurring via both extracellular calcium influx and intracellular calcium release[1].
Desipramine potently binds to the rat norepinephrine transporter with a Ki of 6.2 nM, showing 25-fold selectivity over the rat serotonin transporter (Ki = 158 nM) [3].
Desipramine (1 h) binds to the rat α2D-adrenoceptor with a Ki of 3.4 μM[3].
Desipramine potently binds to the human norepinephrine transporter with a Ki of 0.63 nM, has lower affinity for the human serotonin transporter (Ki = 22 nM), and lacks affinity for the human dopamine transporter (Ki > 10,000 nM)[3].
Desipramine (0.01-10 μM; 20 h) dose-dependently inhibits LPS (HY-D1056)-induced TNF-α release from primary human monocytes[4].
Desipramine (10 μM) reduces TNF-α-induced RANTES release and RANTES mRNA accumulation in A549 human lung epithelial cells[4].
Desipramine (10 μM) represses TNF-α-induced NF-κB activity in A549 human lung epithelial cells[4].
Desipramine (10 μM) reduces TPA (HY-18739)-induced AP-1 activity in A549 human lung epithelial cells[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human hepatoma Hep3B cells
-
Concentration:1 µM, 3 µM, 10 µM, 30 µM, 100 µM, 300 µM, 500 µM
-
Incubation Time:24 h
-
Result:Did not affect cell viability at 1 µM.
Reduced cell viability to 90.2% of control at 3 µM.
Reduced cell viability to 87.4% of control at 10 µM.
Reduced cell viability to 69.1% of control at 30 µM.
Reduced cell viability to 45.9% of control at 100 µM.
Reduced cell viability to 36.1% of control at 300 µM.
Reduced cell viability to 27.8% of control at 500 µM.
Caused statistically significant viability reductions at concentrations ≥3 µM compared to control.
-
Cell Line:human hepatoma Hep3B cells
-
Concentration:10 µM, 30 µM, 100 µM, 300 µM, 500 µM
-
Incubation Time:24 h
-
Result:Increased LDH activity to 105.7% of control at 10 µM.
Increased LDH activity to 109.8% of control at 30 µM.
Increased LDH activity to 150.3% of control at 100 µM.
Increased LDH activity to 227.7% of control at 300 µM.
Increased LDH activity to 255.7% of control at 500 µM.
Caused statistically significant increases in LDH release at all tested concentrations compared to control.
-
Cell Line:human hepatoma Hep3B cells
-
Concentration:100 µM
-
Incubation Time:1 h, 2 h, 4 h, 8 h
-
Result:Increased phosphorylation of ERK1/2 to 185.2% of control at 1 h, 151.5% of control at 2 h, and 138.5% of control at 4 h.
Increased phosphorylation of p38 to 135.1% of control at 1 h and 116.4% of control at 2 h.
Increased phosphorylation of JNK to 118.9% of control at 1 h and 113.9% of control at 2 h.
Maintained unchanged total levels of ERK1/2, JNK, and p38 across all time points.
Caused statistically significant increases in MAPK phosphorylation at the specified time points compared to control.
In Vivo
Desipramine (10 mg/kg; i.p.; daily; 8 days, 30 minutes pre-Ovalbumin nebulization) reduces lung inflammation by decreasing macrophage and lymphocyte counts in Ovalbumin (HY-W250978)-sensitized rats but does not attenuate bronchial hyperresponsiveness[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:LPS-induced BALB/c mice (5-week-old, 17-21 g)[4]
-
Dosage:5, 10, 20 mg/kg
-
Administration:i.p.; single dose (preventive, 30 minutes pre-LPS)
-
Result:Significantly inhibited LPS-induced serum TNF-α production.
Increased mouse survival rate to 70% with preventive 20 mg/kg treatment (vs 10% in saline controls).
-
Animal Model:Ovalbumin-sensitized Brown Norway rats (10-week-old)[4]
-
Dosage:10 mg/kg
-
Administration:i.p.; daily; 8 days (30 minutes pre-ovalbumin nebulization)
-
Result:Did not reduce bronchial hyperresponsiveness to metacholine (measured by enhanced pause, Penh).
Reduced total number of inflammatory cells in bronchoalveolar lavages.
Decreased macrophage count by 52% compared to saline-treated sensitized rats.
Decreased lymphocyte count by 21% compared to saline-treated sensitized rats.
Did not reduce neutrophil or eosinophil counts compared to saline-treated sensitized rats.
Chemical Information
-
CAS. Nr. 50-47-5
-
Appearance Solid
-
Molecular Weight 266.38
-
Formel C18H22N2
-
Color White to off-white
-
SMILES
CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (18)
-
Journal Impact Factor
-
Most Recent
-
Cell
2025 Nov 26;188(24):6861-6872.e14. PMID: 41138730 -
-
Neural Regen Res
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model. [Abstract]2021 Aug;16(8):1660-1670. PMID: 33433498 -
Br J Pharmacol
Serotonergic transmission plays differentiated roles in the rapid and sustained antidepressant-like effects of ketamine. [Abstract]2024 Dec;181(23):4874-4889. PMID: 39238235 -
J Med Chem
Bioisostere-Driven Discovery of SePP: A Selenium-Containing Polypharmacological Agent Relevant to Fragile X Syndrome. [Abstract]2026 Feb 10. PMID: 41666325 -
Pharmaceutics
Laminin Receptor-Mediated Nanoparticle Uptake by Tumor Cells: Interplay of Epigallocatechin Gallate and Magnetic Force at Nano-Bio Interface. [Abstract]2022 Jul 22;14(8):1523. PMID: 35893779
Desipramine purchased from MedChemExpress. Usage Cited in: Pharmaceutics. 2022 Jul 22;14(8):1523. [Abstract]
Figure shows that 10 and 30 μM of Desipramine hydrochloride attenuated EGCG-induced enhancement of MNPcell by 8.9% and 39.3% in the Mag− group, respectively. In the Mag+ group, MNPcell was enhanced up to 6.6-fold by EGCG compared with the control group, which was minorly attenuated by 5.7% and 11.2% by Desipramine hydrochloride at 10 and 30 μM, respectively.
-
J Parkinson Dis
The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease. [Abstract]2020;10(2):523-542. PMID: 31958096 -
Front Endocrinol
The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model. [Abstract]2026 May 5:17:1825379. PMID: 42165019 -
Glia
Potassium channel Kir 4.1 regulates oligodendrocyte differentiation via intracellular pH regulation. [Abstract]2022 Nov;70(11):2093-2107. PMID: 35775976 -
Inflammation
Acid Sphingomyelinase and Acid β-Glucosidase 1 Exert Opposite Effects on Interleukin-1β-Induced Interleukin 6 Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. [Abstract]2021 Aug;44(4):1592-1606. PMID: 33665756 -
Biochim Biophys Acta Mol Basis Dis
Involvement of Kir4.1 in pain insensitivity of the BTBR mouse model of autism spectrum disorder. [Abstract]2023 Mar 28;1869(5):166700. PMID: 36990129 -
Neuropharmacology
Antidepressant-like activity of JZ-1201 in male rodents: a novel selective 5-HT/NE reuptake inhibitor and 5-HT1A receptor partial agonist. [Abstract]2026 Nov 1:298:111009. PMID: 42107524 -
Neurotoxicology
Ropivacaine-induced seizures evoked pain sensitization in rats: Participation of 5-HT/5-HT3R. [Abstract]2022 Dec:93:173-185. PMID: 36209936 -
-
Neuroscience
Acute Administration of Lactate Exerts Antidepressant-like Effect Through cAMP-dependent Protein Synthesis. [Abstract]2024 Mar 26:542:11-20. PMID: 38336096 -
Parkinsons Dis
DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson's Disease Rat Model. [Abstract]2022 Nov 14:2022:1428817. PMID: 36419409 -
Sci Total Environ
Cadmium exacerbates liver injury by remodeling ceramide metabolism: Multiomics and laboratory evidence. [Abstract]2024 May 1:923:171405. PMID: 38432385
Desipramine purchased from MedChemExpress. Usage Cited in: Sci Total Environ. 2024 May 1:923:171405. [Abstract]
Desipramine hydrochloride (Des; 0-50 μM; 24 h). Cell viability of BRL-3A cells after Des intervention was detected by CCK-8. Other groups were compared with 0 μM group.
Desipramine purchased from MedChemExpress. Usage Cited in: Sci Total Environ. 2024 May 1:923:171405. [Abstract]
Desipramine hydrochloride (Des; 12.5 μM; 24 h). The expression levels of apoptosis-related proteins in BRL-3A cells were detected by western blotting.
Desipramine purchased from MedChemExpress. Usage Cited in: Sci Total Environ. 2024 May 1:923:171405. [Abstract]
Desipramine hydrochloride (Des; 12.5 μM; 24 h). Hoechst/PI double staining: Hoechst/PI was used to double stain and observe them under fluorescence microscope (200×). Hoechst 33342 can stain the nucleus with blue fluorescence. PI can stain necrotic cells with red fluorescence.
Desipramine purchased from MedChemExpress. Usage Cited in: Sci Total Environ. 2024 May 1:923:171405. [Abstract]
Desipramine hydrochloride (Des; 12.5 μM; 24 h). The level of LDH in cell culture medium after 12.5 μM Des intervention and/or 20 μM Cadmium exposure for 24 h.
-
Protokoll
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Calcium Spark Assay
Calcium sparks are localized, transient increases in intracellular calcium concentration ([Ca2+]i) that occur in cardiac myocytes and represent elementary events underlying excitation-contraction coupling. These events are generated by the coordinated opening of clusters of ryanodine receptors (RyRs) on the sarcoplasmic reticulum membrane, leading to a brief release of Ca2+ into the cytosol. The detection and analysis of calcium sparks provide insights into the mechanisms of calcium handling and signaling in cardiac cells. Imaging techniques using fluorescent calcium indicators such as Fluo-3 are employed to visualize these subcellular calcium transients with high spatial and temporal resolution. The protocol is based on established methodologies described in primary literature for both experimental measurement and automated analysis of calcium sparks.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Ca2+ Staining Technique
Ca2+ staining is an experimental technique that utilizes specific fluorescent probes (such as Fluo-4 AM, Fura-2, etc.) to qualitatively or quantitatively detect dynamic changes in intracellular Ca2+ concentrations; this is achieved by monitoring the changes in fluorescent signals generated when these probes bind to free intracellular calcium ions. The underlying principle relies primarily on the presence of chelating groups within the probe's molecular structure that possess high affinity for calcium ions.
Reinheit & Dokumentation
-
Data Sheet (287 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Yang DK, et al. Desipramine induces apoptosis in hepatocellular carcinoma cells. Oncol Rep. 2017;38(2):1029-1034. [Content Brief]
[2]. Kishore-Kumar R, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther. 1990;47(3):305-312. [Content Brief]
[3]. Deupree JD, et al. Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram. Eur J Pharmacol. 2007;576(1-3):55-60. [Content Brief]
[4]. Roumestan C, et al. Anti-inflammatory properties of desipramine and fluoxetine. Respir Res. 2007;8(1):35. Published 2007 May 3. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)